CONCEPT provides robust evidence that chondroitin sulfate is superior to placebo and similar to celecoxib in the symptomatic management of osteoarthritis.
Reginster, Jean-Yves
2018 • In Annals of the Rheumatic Diseases, 77 (2), p. 1-2
CONCEPT provides robust evidence that chondroitin sulfate is superior to placebo and similar to celecoxib in the symptomatic management of osteoarthritis..pdf
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
CONCEPT provides robust evidence that chondroitin sulfate is superior to placebo and similar to celecoxib in the symptomatic management of osteoarthritis.
Kardes, S., Comment on CONCEPT by Reginster et al: Are the authors' interpretations supported by the data analysis? (2018) Ann Rheum Dis, 77, p. e10
Reginster, J.Y., Dudler, J., Blicharski, T., Pharmaceutical-grade chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: The ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT) (2017) Ann Rheum Dis, 76, pp. 1537-1543
Bruyère, O., Cooper, C., Pelletier, J.P., A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-from evidence-based medicine to the real-life setting (2016) Semin Arthritis Rheum, 45, pp. S3-S11